Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | FAAH | O00519 | 5/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.45 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26981009 | 1.00 | LMNA (0.52) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| SCHEMBL1032914 | 1.00 | LMNA (0.52) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| SCHEMBL2581397 | 1.00 | LMNA (0.52) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| SCHEMBL28525744 | 1.00 | LMNA (0.52) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| SCHEMBL28477983 | 1.00 | LMNA (0.52) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| Methylamine SCHEMBL9488577 | 0.96 | LMNA (0.49) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| SCHEMBL28488646 | 0.92 | LMNA (0.46) | LMNAFAAHABCB1ZDHHC7CA1 | |
| SCHEMBL19899177 | 0.91 | FAAH (0.44) | LMNAFAAHMAPTPPARD | |
| SCHEMBL28404579 | 0.84 | LMNA (0.48) | LMNAFAAHZDHHC7CA1 | |
| SCHEMBL3179799 | 0.83 | ZDHHC7 (0.46) | LMNAFAAHABCB1ZDHHC7ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2161991-B1 | A METHOD FOR MODULATING THE RELEASE RATE OF MICROENCAPSULATED ACTIVE INGREDIENTS | ENDURA SPA (IT) | 2018-07-25 | — | — | EP | claimed |
| WO-2016020287-A1 | TWO COMPONENT SYSTEM FOR COSMETIC FORMULATIONS | OMYA INTERNATIONAL AG (CH) | 2016-02-11 | — | — | WO | claimed |
| EP-2982363-A1 | Two component system for cosmetic formulations | Omya International AG (CH) | 2016-02-10 | — | — | EP | claimed |
| US-20100173781-A1 | METHOD FOR MODULATING THE RELEASE RATE OF MICROENCAPSULATED ACTIVE INGREDIENTS | ENDURA S.P.A. (IT) | 2010-07-08 | — | — | US | claimed |
| EP-2161991-A2 | A METHOD FOR MODULATING THE RELEASE RATE OF MICROENCAPSULATED ACTIVE INGREDIENTS | ENDURA S.p.A. (IT) | 2010-03-17 | — | — | EP | claimed |
| WO-2009000545-A2 | A METHOD FOR MODULATING THE RELEASE RATE OF MICROENCAPSULATED ACTIVE INGREDIENTS | ENDURA S.P.A. (IT) | 2008-12-31 | — | — | WO | claimed |
| CN-1217640-C | Water-in-oil emulsion type cosmetic composition | PROCTER & GAMBLE (US) | 2005-09-07 | — | — | CN | claimed |
| CN-1454071-A | Water-in-oil emulsion type cosmetic composition | PROCTER & GAMBLE (US) | 2003-11-05 | — | — | CN | claimed |
| US-20030118532-A1 | Water-in-oil emulsified make-up composition | THE PROCTER & GAMBLE COMPANY | 2003-06-26 | — | — | US | claimed |
| WO-2001091704-A1 | WATER-IN-OIL EMULSIFIED MAKE-UP COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2001-12-06 | — | — | WO | claimed |
| US-5891846-A | OIL IN WATER EMULSION | SHISEIDO COMPANY, LTD. (JP) | 1999-04-06 | — | — | US | claimed |
| EP-0694308-A1 | CYCLOSPORIN-CONTAINING EMULSION COMPOSITION | SHISEIDO COMPANY LIMITED (JP) | 1996-01-31 | — | — | EP | claimed |
| CN-117940105-A | Cosmetic composition | 株式会社资生堂 | 2024-04-26 | — | — | CN | disclosed |
| EP-4294353-A1 | ANTI-POLLUTION AGENT | Omya International AG (CH) | 2023-12-27 | — | — | EP | disclosed |
| EP-3743164-B1 | SURFACE-REACTED CALCIUM CARBONATE FOR MODIFYING THE BIOMECHANICAL PROPERTIES OF THE SKIN | OMYA INT AG (CH) | 2023-10-04 | — | — | EP | disclosed |
| CN-111655342-B | Surface-reacted calcium carbonate as skin appearance modifier | 欧米亚国际集团 | 2023-09-12 | — | — | CN | disclosed |
| EP-0711143-B1 | COSMETIC COMPOSITION CONTAINING HYDROXYACIDS | UNILEVER PLC (GB) | 1999-05-06 | — | — | EP | disclosed |
| EP-0715856-A1 | KERATIN-STORABLE ANTIFUNGAL COMPOSITION FOR EXTERNAL USE | TOKO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1996-06-12 | — | — | EP | disclosed |
| EP-0711143-A1 | COSMETIC COMPOSITION CONTAINING HYDROXYACIDS | UNILEVER PLC (GB) | 1996-05-15 | — | — | EP | disclosed |
| WO-1995003779-A1 | COSMETIC COMPOSITION CONTAINING HYDROXYACIDS | UNILEVER PLC (GB) | 1995-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118532-A1 | Water-in-oil emulsified make-up composition | LIPA, LRBA, AQP1 | LMNA 144/4885FAAH 1915/4885ABCB1 2090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.